Piramal Pharma (PPLPHARMA) — Announcement

Piramal Pharma clarified that a recent news article about its share price rising over 10% was driven by market dynamics, not material information requiring disclosure under SEBI regulations, and confirmed no undisclosed events exist.

📄 View Original Announcement (PDF)

📊 Stock Analysis — PPLPHARMA ✨ Ask AI About This

About Piramal Pharma Limited (PPLPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹23,244.56 Cr P/E: 582.9

View full PPLPHARMA stock details →

📡 Get AI alerts when PPLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track PPLPHARMA — Free

💡 Ask AI about this filing

"How does this announcement affect Piramal Pharma Limited's outlook?" "What did Piramal Pharma Limited announce on 23 June 2026?" "Is this positive or negative for PPLPHARMA?"

Ask AI Free →

📊 More PPLPHARMA filings

See all PPLPHARMA filings →

🔥 Also filed on 23 June 2026

RAYMONDREL Raymond Realty Limited Annual Report PRAXIS Praxis Home Retail Limited Financial Results PREMIER Premier Limited Financial Results RAYMONDLSL Raymond Lifestyle Limited Annual Report RAYMOND Raymond Limited Annual Report REPCOHOME Repco Home Finance Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PPLPHARMA files new disclosures

Track PPLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.